Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Am J Transplant. 2017 Nov 1;18(4):843–854. doi: 10.1111/ajt.14523

Figure 3. CD47mAb-treated donor kidneys exhibit histological evidence of IRI protection.

Figure 3

(A) In the syngenic model and the allogeneic model, CD47mAb-treated donor kidneys showed less histological injury when examined 48 hours after transplantation (magnification ×200) than kidneys receiving control IgG antibody. (B) Histological sections were scored in a blinded manner for ATI and ATN. The CD47mAb-treated groups had significantly decreased scores of ATI and ATN in both models.